Advancing science and medicine, Craig Venter
Interviewee: Craig Venter. Craig Venter talks about advancing science and medicine.
Well it was a threat to the old way of doing things, it was not a threat in terms of what the goals of the genome project were. You know, we were doing this 'cause we wanted to advance science, we wanted to get more rapid cancer treatments, change the way discoveries were made, this was being done as a public benefit, scientific benefit project, not as a long-term means to fund laboratories.
craig venter,human genome project,benefit project,advancing science,public benefit,cancer treatments,interviewee,discoveries,medicine
The leaders of the private and public genome projects, Craig Venter and Francis Collins.
Craig Venter talks about the public won the race.
Craig Venter, leader of the private effort at Celera Genomics, speaks about his company's reliance on the public data for reassembly of the Celera sequence.
Craig Venter speaks about the public sector's reaction to his plans to sequence the genome at a private company, Celera Genomics.
Craig Venter, leader of the private effort at Celera Genomics, speaks about the excitement the race to sequence the human genome generated.
Craig Venter talks about techniques and the new biology.
Craig Venter talks about public's reaction to the 1995 publication of the genetic code.
Commentators on the genome sequence (Human Genome Project). Top: William Clinton, Ewan Birney, John Sulston. Bottom: Jim Watson, Craig Venter.
Craig Venter, the leader of the private genome effort at Celera Genomics, talks about the differences between the public and private approaches.
Origins of the EST project.